Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial
Michiel S. van der Heijden, Yohann Loriot, Ignacio Durán, Alain Ravaud, Margitta Retz, Nicholas J. Vogelzang, B. Nelson, Jingjing Wang, Xiaodong Shen, Thomas Powles
Topics & Concepts
AtezolizumabMedicineMetastatic Urothelial CarcinomaOncologyChemotherapyInternal medicineDiscontinuationDocetaxelAdverse effectImmunotherapyUrologyCancerBladder cancerPembrolizumabUrothelial carcinomaBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesCancer Immunotherapy and Biomarkers